About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 81 record(s)
Req # A-2021-001264
Adverse Drug Reaction (ADR) for INSULIN LISPRO. Report number: E2B_03868853.Organization: Health Canada
January 2022
Req # A-2021-001705
Adverse Drug Reactions (ADRs). Report numbers: 944183, 948200, 947996, 948415, 945490, 945585, 945681, 945833, 946033, 946036.Organization: Health Canada
January 2022
Req # A-2020-000790
The name of every manufacturer of the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device since the device first issuance date, that being September 20, 1999.Organization: Health Canada
January 2022
Req # A-2020-000791
Every Medical Device License of the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device since the device first issuance date, that being September 20, 1999.Organization: Health Canada
January 2022
Req # A-2019-001360
Adverse Reaction Report (AER). Report number: E2B_02492809.Organization: Health Canada
January 2021
Req # A-2019-001366
Adverse Reaction Report (AER). Report number: E2B_02119211.Organization: Health Canada
January 2021
Req # A-2019-001548
Adverse Reaction Report (AER). Report number: E2B_02763703.Organization: Health Canada
January 2021
Req # A-2020-000343
Adverse Reaction Report (AER) for THIOTEPA. Report number: E2B_03027201.Organization: Health Canada
January 2021
Req # A-2020-000350
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02945736, E2B_02889429, E2B_02941549, E2B_02840380, E2B_02824697.Organization: Health Canada
January 2021
Req # A-2020-000624
Adverse Reaction Reports (AERs). Report numbers: E2B_03069863, E2B_03096494.Organization: Health Canada
January 2021